| Filed On | Filing |
|---|---|
| 18 Sep 2024 |
Form 3/A: DSS, Inc., 10% owner · Impact Biomedical Inc
Holds 1,345,482 shares of Common Stock |
| 08 Apr 2005 | Form 3/A: Greenstein Ira A, Director |
| 08 Apr 2005 |
Form 3/A: Fagenson Robert B, Director
Holds 800,000 shares of Common Stock |
Loading...
